Bash Biotech
Phase 3We study the interactions between the host and oral/gut microbiome through the integration of multi-omics data and employ this information to identify effective drug targets and prognostic biomarkers. We also perform drug repositioning applications to use the existing drugs for treatment of such diseases and identify their potential side effects.
About
We study the interactions between the host and oral/gut microbiome through the integration of multi-omics data and employ this information to identify effective drug targets and prognostic biomarkers. We also perform drug repositioning applications to use the existing drugs for treatment of such diseases and identify their potential side effects.
Funding History
1Total raised: $2M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile